TITAN PHARMACEUTICALS INC

Titan Pharmaceuticals Inc is a US-based company operating in IT Services industry. The company is headquartered in New York City, New York. Titan Pharmaceuticals, Inc. is a pharmaceutical company. Its product pipeline includes Kappa Opioid Receptor Agonist (TP-2021) Implant, which is used for the treatment of moderate-to-severe chronic pruritus, and Nalmefene Implant, which is for the prevention of relapse in OUD patients following detoxification from opioids Its product development programs are in non-clinical stages of development.

Peers: Ampio Pharmaceuticals, Inc. TREX WIND-DOWN, INC. Avenir Wellness Solutions, Inc. Eloxx Pharmaceuticals Inc Evofem Biosciences Inc Johnson & Johnson KALA BIO Inc MJ Holdings, Inc. OTONOMY, INC.

Dive deeper

Financial snapshot data is not available right now.

Stock Price

Market Cap: $6.13 Million